AGENDA
8:00 am – 8:30 am | REGISTRATION & BREAKFAST
8:30 am – 8:45 am | WELCOME & INTRODUCTION
-Dr. Cornell Stamoran, Founder and Chair, Catalent Institute
NEW BIOLOGIC MODALITIES
8:45 am – 9:30 am | ENGINEERING NEW VIRUSES FOR THERAPEUTIC GENE DELIVERY
-Dr. David Schaffer, Professor, UC Berkeley
9:30 am – 10:15 am | IDENTIFICATION OF RECOMBINANT ANTIBODIES TO THE PLASMINOGEN ACTIVATION SYSTEM FOR THE TREATMENT OF AGGRESSIVE CANCERS – USING ADCs AS AN EXAMPLE
-Dr. Charles Craik, Professor, UC San Francisco
10:15 am – 10:30 am | BREAK
10:30 am – 11:15 am | IMPROVED METHODS FOR CELL LINE DEVELOPMENT OF DIFFICULT TO EXPRESS PROTEINS
-Dr. Greg Bleck, Global Head of R&D, Catalent Biologics
11:15 am – 12:00 pm | DEVELOPMENT OF MULTIVALENT PROTEIN CONJUGATES AS A STRATEGY TO ENGINEER DRUG PHARMACOLOGY
-Dr. Wesley Jackson, CEO and Co-Founder, Valitor, Inc.
12:00 pm – 1:30 pm | NETWORKING LUNCH & MEET THE EXPERTS
THE FUTURE OF BIOLOGIC DRUG DELIVERY
1:30 pm – 2:15 pm | HIGH EFFICIENCY ENCAPSULATION OF SPARINGLY SOLUBLE AMORPHOUS DRUG PRECIPITATES IN LIPOSOMES FOR PARENTERAL AND ORAL DELIVERY
-Dr. Francis Szoka, Professor, UC San Francisco
2:15 pm – 3:00 pm | LOCAL DRUG ACTIVATION – GETTING THERAPEUTICS TO THE AREA OF THE BODY WHERE YOU NEED THEM
-Dr. Jose Mejia, CEO, Shasqi
3:00 pm – 3:15 pm | BREAK
3:15 pm – 4:00 pm | TBD
4:00 pm – 5:00 pm | Panel Discussion | Title: CHALLENGES, MISCONCEPTIONS AND CRAZY PREDICTIONS FOR THE FUTURE OF BIOLOGICS
Panelists:
-Dr. Regis Kelly, Executive Director & Byers Family Distinguished Professor, QB3
-Dr. Penelope Drake, Director, R&D, Catalent Biologics
-Additional Speakers TBD
-Moderated by Dr. Ronak Savla, Manager, Scientific Affairs, Catalent
5:00 pm – 7:30 pm NETWORKING RECEPTION